These data altogether suggest that the beneficial treatment effect of GA and DL in FUS- and SOD1-ALS MNs might be because of a metabolic rescue by restoring the NAD(P)H reservoir. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.